Bioneer
Bioneer is a South Korean biotech founded in 1992 that develops and sells molecular biology reagents, automated laboratory instruments, and CE-IVDR certified in vitro diagnostic kits to life science researchers, clinical laboratories, and industrial/applied science customers across Korea, China, North America, and international markets.
- Company typePrivate
- Founded1992
- HeadquartersDaejeon, South Korea
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bioneer does
Bioneer Corporation is a privately held South Korean biotechnology company founded in 1992 and headquartered in Daejeon, with a US sales subsidiary (Bioneer, Inc.) in Oakland, California. The company develops and sells molecular biology research tools, automated laboratory instruments, and in vitro diagnostic kits across three primary customer segments: life science researchers, clinical/molecular diagnostic laboratories, and industrial/applied science users in agricultural and food safety markets. Its product lines span nucleic acid extraction reagents (AccuPrep, MagListo, EcoQprep), PCR and RT-PCR premix kits (AccuPower family, including RocketScript, RocketPlex, CycleScript, ProFi Taq, and HotStart variants), automated instruments (ExiPrep 16/48/96 extractors, ExiCycler 96 real-time PCR, AllInOneCycler, ExiProgen protein synthesis system, AccuLoader sample loader), and CE-IVDR certified diagnostic kits (AccuPower HIV-1 Quant Kit, Respiratory Virus Multiplex Kit).
The company differentiates technically through several claimed world-first and proprietary technologies, including the ExiProgen automatic protein synthesis and purification system, the AccuLoader precision multi-well plate sample loader, Dual-HotStart RT-PCR chemistry, and Cyclic Temperature Reverse Transcription (CTRT) technology. Bioneer holds ISO 9001 and ISO 13485 quality system certifications and, in March 2026, secured CE-IVDR Class D certification (the highest risk class) for its HIV-1 quantitative diagnostic kit and CE-IVDR certification for a multiplex respiratory virus kit on its ExiStation FA 96 platform.
Bioneer generates revenue primarily through one-time sales of reagents, instruments, and diagnostic kits, plus professional services for gene synthesis, oligonucleotide synthesis, Sanger sequencing, and GPScreen drug target identification. Distribution is direct via five regional e-commerce storefronts (USA, Canada, Korea, China, International) with local language support, supplemented by quote-based enterprise sales; no channel partners or distributors are disclosed. Leadership is founder-led, with Han-Oh Park serving as founder and CEO, and the company is privately held with no disclosed institutional investors, funding rounds, or revenue figures.
Bioneer firmographics
Firmographics- Name
- Bioneer
- Legal name
- BIONEER CORPORATION
- Website
- https://bioneer.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Bioneer is a South Korean biotech founded in 1992 that develops and sells molecular biology reagents, automated laboratory instruments, and CE-IVDR certified in vitro diagnostic kits to life science researchers, clinical laboratories, and industrial/applied science customers across Korea, China, North America, and international markets.
- Ownership category
- akta.pro rank
Bioneer industry classification
Industry- Product category
- Molecular Diagnostics and Life Science Research Tools
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
- akta.pro secondary industries
- Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)
Keywords
Where Bioneer is headquartered
LocationHeadquarters
- HQ city
- Daejeon
- HQ country
- South Korea
- HQ region
- Asia
Offices3 records
Markets served
Bioneer business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
Revenue model
- Molecular Diagnostics Products: Sale of IVD kits including HIV-1 Quant Kit (CE-IVDR certified), respiratory virus multiplex kits, SARS-CoV-2 tests, and other diagnostic assays for use on company's ExiStation platform
- Life Science Research Reagents: Sale of PCR/RT-PCR reagents, enzymes, extraction kits, oligonucleotides, gene synthesis products, and CRISPR tools to research institutions
- Laboratory Instruments: Sale and distribution of automated instruments including ExiPrep nucleic acid extractors, ExiCycler real-time PCR systems, AllInOneCycler PCR instruments, and ExiProgen protein synthesis systems
- Custom Services: Gene synthesis services, Sanger sequencing services, CRISPR validation services, and custom oligo synthesis
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | EcoQprep mRNA Kit |
| Unit Pricing | Pay-as-you-go | AccuPower RocketScript RT-PCR PreMix |
| Unit Pricing | Pay-as-you-go | AccuPower RocketPlex RT-PCR PreMix |
| Unit Pricing | Pay-as-you-go | AccuPower RocketScript Cycle RT PreMix |
| Unit Pricing | Pay-as-you-go | AccuPower ProFi Taq PCR PreMix |
| Unit Pricing | Pay-as-you-go | AccuPower CycleScript RT PreMix |
| Unit Pricing | Pay-as-you-go | AccuLoader Precision Sample Loading Device |
| Other | Multi-year contract | AllInOneCycler PCR System |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Bioneer product offering
Product offeringCore offering
Bioneer manufactures and sells an integrated portfolio of molecular biology products spanning nucleic acid extraction instruments and kits (ExiPrep, AccuPrep, EcoQprep), PCR/RT-PCR reagents (AccuPower line), laboratory instruments (ExiCycler, AllInOneCycler, ExiProgen), and CE-IVDR certified molecular diagnostic kits (HIV-1 Quant Kit, respiratory virus multiplex kits) for use on its ExiStation FA 96 platform. The company also provides custom services such as gene synthesis, oligonucleotide synthesis, siRNA/miRNA production, and GPScreen drug target identification for research and clinical laboratory customers.
Product overview
Bioneer is a South Korean biotechnology company offering an integrated portfolio of molecular biology products and molecular diagnostics solutions. The core portfolio consists of AccuPower branded PCR/RT-PCR reagent kits (including HotStart, Multiplex, RocketScript, RocketPlex, CycleScript, and ProFi Taq variants), AccuPrep branded DNA/RNA extraction and preparation products, and MagListo magnetic bead-based extraction systems. These reagents are used with Bioneer's instrument systems including the ExiPrep 96 Lite and ExiPrep 48 Dx automated nucleic acid extraction instruments, the ExiCycler 96 and AllInOneCycler real-time and conventional PCR systems, and the ExiStation FA 96 integrated molecular diagnostic platform. For diagnostics, Bioneer provides CE-IVDR certified kits including the AccuPower HIV-1 Quant Kit and respiratory virus multiplex kits, alongside research-use-only products like SARS-CoV-2 detection kits. The company also offers specialty products including EcoQprep mRNA isolation kits, CRISPR reagents, gene synthesis services, and the ExiProgen automated protein synthesis system. Services include oligo synthesis, siRNA/miRNA production, gene synthesis, Sanger sequencing, and GPScreen drug target identification. The company operates regional sites for USA/Canada, International, China, and Korea markets.
Differentiator
Problem solved
Functional benefit
Brands
- AccuPower: PCR and RT-PCR reagents and kits including HotStart PCR PreMix, RocketScript RT-PCR PreMix, and quantitative PCR products
- AccuPrep
- ExiProgen
- ExiStation
- ExiPrep
- Exicycler
- AllInOneCycler
- AccuLoader
- EcoQprep
- SAMiRNA
Products and services
- ExiStation FA 96 Molecular Diagnostic System High-throughput molecular diagnostic system for automated nucleic acid extraction and real-time PCR analysis, used in clinical diagnostic laboratories and hospitals.
- AccuPower HIV-1 Quant Kit CE-IVDR Class D certified quantitative HIV-1 assay for HIV viral load monitoring, designed for use on the ExiStation FA 96 molecular testing system.
- AccuPower SARS-CoV-2 Real-Time RT-PCR Kit In vitro diagnostic kit for detecting SARS-CoV-2 (E gene and RdRp gene) RNA from patient samples such as sputum and swabs through real-time PCR.
- Respiratory Virus Multiplex Kit CE-IVDR certified multiplex kit detecting SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) for clinical diagnostic use.
- ExiPrep 96 Lite Nucleic Acid Extractor High-capacity automated nucleic acid extraction instrument processing up to 96 samples within 30 minutes using magnetic rod method, for use in research and clinical laboratories.
- ExiPrep 48 Dx Nucleic Acid Extractor Fully automated nucleic acid extraction instrument handling 8 to 48 samples per run with automatic pipetting and UV sterilization, designed for diagnostic workflows.
- AllInOneCycler PCR System PCR system with unique thermal block technology and ramp rates up to 6.5°C/sec, featuring interchangeable 96-well and 384-well blocks for research use.
- ExiCycler 96 Real-Time PCR System Real-time PCR instrument for quantitative detection; the first Real-Time PCR instrument introduced in Asia by Bioneer.
- AccuLoader Precision Sample Loading Device World's first patented precision auxiliary device for sample loading into multi-well plates, featuring barcode scanning and automatic well positioning.
- ExiProgen Protein Synthesis System World's first automatic protein synthesis and purification system for high-quality protein production services.
- EcoQprep mRNA Kit Magnetic bead-based system for isolating high-quality mRNA with poly(A) tails from cultured cells, animal tissues, and plant tissues using oligo(dT) magnetic nanobeads.
- AccuPower RocketScript RT-PCR PreMix & Master Mix One-step RT-PCR reagent combining thermostable RocketScript Reverse Transcriptase and ProFi Taq DNA polymerase for cDNA synthesis and amplification.
- AccuPower RocketPlex RT-PCR PreMix & Master Mix Multiplex RT-PCR kit enabling simultaneous cDNA synthesis and amplification of up to 10 target genes using HotStart Taq DNA Polymerase.
- AccuPower ProFi Taq PCR PreMix & Master Mix High-fidelity PCR kit using ProFi Taq DNA polymerase for accurate long-range amplification of DNA fragments up to 20-30 kb.
- AccuPower CycleScript RT PreMix & Master Mix RT-PCR kit utilizing Cyclic Temperature Reverse Transcription (CRCT) patent technology for improved cDNA synthesis efficiency.
- MagListo 5M Viral DNA/RNA Extraction Kit Magnetic bead-based extraction kit for isolating viral DNA/RNA from clinical samples for diagnostic workflows.
- Gene Synthesis Service Custom gene synthesis service for constructing DNA sequences for research and industrial applications.
- GPScreen Drug Target and Toxicity Identification Service Drug target and toxicity identification service using yeast-based screening platforms for pharmaceutical and biotech researchers.
- Oligonucleotide Synthesis Service Custom oligonucleotide synthesis service for research customers, including siRNA and miRNA production.
- DUALED Blue/White Transilluminator LED transilluminator for visualization of nucleic acid gels with blue/white light to avoid UV damage, for molecular biology laboratories.
Quantifiable outcome
- CE-IVDR Class D certification for HIV-1 Quant Kit enables EU market access and Global Fund procurement listing
Companies that use Bioneer
Customer profileSegments3 records
Bioneer technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
Feature9 records
Bioneer partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights4 records
Bioneer competitors and assessment
Company assessmentEmerging players
- Standard BioTools (Fluidigm): Standard BioTools (formerly Fluidigm) is an emerging player in specialized PCR and genomics instrumentation (Juno, Biomark). It overlaps with Bioneer's instrument portfolio for targeted molecular biology research applications.
- Genolution: Genolution is a Korean emerging player in nucleic acid extraction instruments (Nextractor), directly competing with Bioneer's ExiPrep line. The two companies are referenced as physically compatible competitors in the sample-prep market.
Broad incumbents
- Hologic: Hologic's Panther and Panther Fusion systems offer automated molecular diagnostics for infectious disease, competing with Bioneer's ExiStation FA 96 in clinical lab settings. It is a broader women's health and diagnostics incumbent.
- Roche Diagnostics: Roche Diagnostics is a broad incumbent in molecular diagnostics, including the cobas systems and viral load assays. It is the dominant supplier for HIV viral load testing globally and a key competitor for Bioneer's HIV-1 Quant Kit in the Global Fund procurement channel.
- Cepheid (Danaher): Cepheid is a broad incumbent in molecular diagnostics with the GeneXpert platform delivering integrated extraction-to-result workflows for infectious disease. It competes against Bioneer's ExiStation FA 96 in centralized clinical lab settings.
- Thermo Fisher Scientific: Thermo Fisher is a broad incumbent in molecular biology tools and diagnostics via the Applied Biosystems and Invitrogen brands (PCR instruments, RT-PCR kits, extraction reagents). It is a much larger competitor with deeper global distribution and broader biopharma relationships.
Direct peers
- Bio-Rad Laboratories: Bio-Rad is a direct peer in PCR instrumentation and reagents (CFX real-time PCR systems, thermal cyclers, and reagent kits) directly competing with Bioneer's ExiCycler and AllInOneCycler product lines in research and clinical labs.
- Takara Bio: Takara Bio is a direct peer offering PCR reagents, nucleic acid extraction kits, and molecular biology research tools of comparable size and product breadth. Both companies serve academic and biotech researchers with reagent catalogs centered on PCR and cloning workflows.
- Qiagen: Qiagen is a direct peer in nucleic acid extraction, PCR reagents, and molecular diagnostics. Both companies sell sample-prep kits, PCR consumables, and IVD assays targeting clinical and research customers; Qiagen's QIAsymphony and QIAcuity systems compete against Bioneer's ExiPrep and ExiStation platforms.
- Seegene: Seegene is a Korean-headquartered direct peer specializing in multiplex molecular diagnostics, particularly syndromic PCR panels. Both companies compete in Asian and global IVD markets with multiplex respiratory and infectious disease assays.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Bioneer social profiles
Digital presenceBioneer compliance and trust
Trust signalCompliance5 records
Bioneer financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioneer leadership team
Management profileNumber of profiles
Bioneer funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioneer M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioneer
What does Bioneer do?
Bioneer manufactures and sells an integrated portfolio of molecular biology products spanning nucleic acid extraction instruments and kits (ExiPrep, AccuPrep, EcoQprep), PCR/RT-PCR reagents (AccuPower line), laboratory instruments (ExiCycler, AllInOneCycler, ExiProgen), and CE-IVDR certified molecular diagnostic kits (HIV-1 Quant Kit, respiratory virus multiplex kits) for use on its ExiStation FA 96 platform. The company also provides custom services such as gene synthesis, oligonucleotide synthesis, siRNA/miRNA production, and GPScreen drug target identification for research and clinical laboratory customers.
Is Bioneer a public or private company?
Bioneer is a private company. It is currently operating.
When was Bioneer founded?
Bioneer was founded in 1992. It employs 251 to 500 people.
Where is Bioneer based?
Bioneer is headquartered in Daejeon, South Korea, in the Asia region.
How does Bioneer make money?
Four revenue lines are on record. Molecular Diagnostics Products are the primary driver. The others are life Science Research Reagents, laboratory Instruments and custom Services.
Who are Bioneer's main competitors?
Emerging players on record are Standard BioTools (Fluidigm) and Genolution. Broad incumbents are Hologic, Roche Diagnostics, Cepheid (Danaher) and Thermo Fisher Scientific. Direct peers are Bio-Rad Laboratories, Takara Bio, Qiagen and Seegene.
Does Bioneer have an API?
No public API is recorded for Bioneer.
What industry is Bioneer in?
Bioneer's product category is Molecular Diagnostics and Life Science Research Tools. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGAEAD, Genomics & Molecular Diagnostics (Trial Support). Its NAICS code is 334516 and its SIC code is 3826.